Reporting | Survey | Antenatal Records | |||
---|---|---|---|---|---|
Analysis | Indicators | Routine (2016) | MICS (2014) | Paper (2016) | eRegistry (2017) |
National baseline (applied to 2017) | % of all pregnant women who have completed the appropriate tetanus toxoid vaccination schedule | NA | NA | 85.4 | 92.1 |
% of pregnant women taking the appropriate iron or folate supplementation | NA | NA | 90.3 | 64.4 | |
% of women with hypertensive disorders in pregnancy who are correctly managed | NA | 68.9† | 15‡ | 35‡ | |
% of women with diabetes with appropriate case management | 71.9 | 35.1† | 7‡ | 10‡ | |
% of women with pre-eclampsia during pregnancy who are correctly managed | 51.7 | 72.9† | 11‡ | 14‡ | |
Anemia | 27* | 27* | 37.3 | 37.7 | |
Severe anemia | 0.272* | 0.272* | 0 | 0.1 | |
BMI | 3.1* | 3.1* | 2.8 | 4.4 | |
National target assuming 90% coverage in public sector (applied to 2018–2025) | % of all pregnant women who have completed the appropriate tetanus toxoid vaccination schedule | NA | NA | 92,0 | 95,7 |
% of pregnant women taking the appropriate iron or folate supplementation | NA | NA | 94.7 | 80.6 | |
% of women with hypertensive disorders in pregnancy who are correctly managed | NA | 75.5† | 53.6 | 64.5 | |
% of women with diabetes with appropriate case management | 84.7 | 47.3† | 49.2 | 50.9 | |
% of women with pre-eclampsia during pregnancy who are correctly managed | 73.6 | 74.5† | 51.4 | 50.9 | |
Anemia | 27.2* | 27.2* | 37.3 | 37.7 | |
Severe anemia | 0.272* | 0.272* | 0 | 0.1 | |
Body mass index (BMI) | 3.1* | 3.1* | 2.8 | 4.4 |